CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-02). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 1975 · Search date 2026-08-02 · Methodology v0.6

100% watermelon juice,
does it really help with Improved vascular function in healthy postmenopausal women?

30-Second Summary
D
Evidence Grade D · 28 · Safety caution
Measured compounds and their pathway were real, but flow-mediated dilation, pulse-wave velocity, and ambulatory pressure did not improve
Watermelon juice can deliver substantial sugar, so people managing diabetes or glucose should watch the amount. Watermelon allergy and bloating in irritable bowel syndrome are also possible.
What the
research shows
The grade is D with 28 points. Twenty-one healthy postmenopausal women were randomized and 17 completed the crossover trial; some serum analyses included only 16. Drinking 720 mL of 100% watermelon juice daily for four weeks did not change flow-mediated dilation, pulse-wave velocity, ambulatory blood pressure, or pulse pressure. Between-treatment confidence intervals were not reported.
What the
ads claim
Citrulline's role in nitric-oxide production is established biochemistry. It did not translate into improved flow-mediated dilation or arterial stiffness in this trial.
*

Useful facts when choosing a product

  • The daily 720-mL juice dose contained measured amounts of 14.4+/-0.34 mg lycopene, 1.15 g arginine, and 1.63 g citrulline.
  • Citrulline contributes to nitric-oxide production through arginine metabolism. That biochemical role is separate from demonstrated vascular benefit.
  • Watermelon originated in Africa and reached China between the Five Dynasties and Song periods. No classical source text was checked for this verdict.
Gap Measurement · Verdict 1975 · D 28
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Twenty-one healthy postmenopausal women were randomized, 17 completed both four-week watermelon-juice and isocaloric-placebo periods separated by a two-week washout, and some serum analyses included 16. NCT03626168 listed serum lycopene, flow-mediated dilation, and pulse-wave velocity as main outcomes, matching the paper. Registration was retrospective, and the current record labels the study non-randomized, conflicting with the paper's randomized crossover design. American Heart Association and NIH-related grants funded the work. Frey Farms supplied juice but was not listed as a funding source.

02

Why this is classified as D (28)

Every vascular surrogate was null in one small short crossover trial, while missing confidence intervals prevent exclusion of meaningful benefit. This gives D with 28 points.

Counterpoint. Missing intervals leave some room for benefit, but the most direct trial was null across all vascular outcomes.

Rejudgment record. Cross-check applied — All vascular surrogates null in a 21-person four-week crossover trial with no between-treatment confidence intervals

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE0Null
PrecisionCXNo pooled confidence interval could be confirmed

The scoring table and the verdict agree (D).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Improved vascular function with 100% watermelon juiceDAll vascular outcomes were null in the four-week crossover trial.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Double-blind randomized isocaloric-placebo four-week crossover trial16American Heart Association and NIH-related grants; juice supplied by Frey FarmsFlow-mediated dilation, pulse-wave velocity, ambulatory blood pressure, and pulse pressureAll null; between-treatment CIs not reported; fasting glucose rose modestlyAll registered vascular outcomes null
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-02).

Ellis AC, Mehta T, et al. Daily 100% watermelon juice consumption and vascular function among postmenopausal women: A randomized controlled trial. Nutrition, Metabolism and Cardiovascular Diseases. 2021;31:2959-2968.
checked
ClinicalTrials.gov. NCT03626168.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-02 · Corrections: none

Cite this verdict

100% watermelon juice x vascular function in healthy postmenopausal women Evidence Grade D card
[Chamgap] 100% watermelon juice x vascular function in healthy postmenopausal women — Evidence Grade D·28. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/heart/watermelon-juice-postmenopausal-vascular-function/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.